GT200900282A - [4(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2h-quinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo sales de sulfonilurea, y las formas y métodos relacionados con el mismo. - Google Patents
[4(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2h-quinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo sales de sulfonilurea, y las formas y métodos relacionados con el mismo.Info
- Publication number
- GT200900282A GT200900282A GT200900282A GT200900282A GT200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A
- Authority
- GT
- Guatemala
- Prior art keywords
- ilo
- sulfonylide
- phenyll
- thiophen
- quinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE SULFONILUREA QUE SE HAN AISLADO COMO SOLIDOS CRISTALINOS DE ALTA PUREZA LOS CUALES SON DE UTILIDAD EN CUADROS DE TROMBOSIS LAS CUALES SON LA PRINCIPAL CAUSA DE MUERTE EN EL MUNDO INDUSTRIALIZADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92732807P | 2007-05-02 | 2007-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200900282A true GT200900282A (es) | 2010-05-21 |
Family
ID=39651344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200900282A GT200900282A (es) | 2007-05-02 | 2009-10-30 | [4(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2h-quinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo sales de sulfonilurea, y las formas y métodos relacionados con el mismo. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090042916A1 (es) |
EP (1) | EP2076510A2 (es) |
JP (1) | JP2010526105A (es) |
KR (1) | KR20100020455A (es) |
CN (1) | CN101720324A (es) |
AU (1) | AU2008247457A1 (es) |
BR (1) | BRPI0810800A2 (es) |
CA (1) | CA2686221A1 (es) |
CO (1) | CO6241155A2 (es) |
EA (1) | EA200901474A1 (es) |
EC (1) | ECSP099779A (es) |
GT (1) | GT200900282A (es) |
IL (1) | IL201829A0 (es) |
MA (1) | MA31397B1 (es) |
MX (1) | MX2009011836A (es) |
TN (1) | TN2009000452A1 (es) |
WO (1) | WO2008137809A2 (es) |
ZA (1) | ZA200907493B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200804241B (en) * | 2005-11-03 | 2009-09-30 | Portola Pharm Inc | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quina-zolin-3-yl)-phenyl]-5-chlorothiophen-2-yl-sulfonylureas and forms and methods related thereto |
US20090156620A1 (en) * | 2007-05-02 | 2009-06-18 | Portola Pharmaceuticals, Inc. | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
WO2011006169A1 (en) | 2009-07-10 | 2011-01-13 | Portola Pharmaceuticals, Inc. | Methods for diagnosis and treatment of thrombotic disorders mediated by cyp2c19*2 |
WO2011088152A1 (en) | 2010-01-12 | 2011-07-21 | Portola Pharmaceuticals, Inc. | Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |
WO2011137459A1 (en) * | 2010-04-30 | 2011-11-03 | Portola Pharmaceuticals, Inc. | Dosage forms of elinogrel and methods of injectable administration thereof |
US8987285B2 (en) * | 2010-12-03 | 2015-03-24 | Portola Pharmaceuticals, Inc. | Pharmaceutical compositions, dosage forms and new forms of the compound of formula (I), and methods of use thereof |
CN106777526B (zh) * | 2016-11-25 | 2020-05-01 | 江苏大学 | 基于遗传算法的高温高压离心式叶轮多学科优化方法 |
US10933096B2 (en) | 2017-12-22 | 2021-03-02 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
WO2019126557A1 (en) * | 2017-12-22 | 2019-06-27 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847925A (en) * | 1971-07-15 | 1974-11-12 | En Nom Collectif Science Et Ci | Benzenesulfonyl semicarbazides |
DE3134780A1 (de) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
US4720450A (en) * | 1985-06-03 | 1988-01-19 | Polaroid Corporation | Thermal imaging method |
US5314902A (en) * | 1993-01-27 | 1994-05-24 | Monsanto Company | Urea derivatives useful as platelet aggregation inhibitors |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
ATE309999T1 (de) * | 2000-02-04 | 2005-12-15 | Portola Pharm Inc | Blutplättchen-adp-rezeptor-inhibitoren |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
DE60144284D1 (de) * | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
AU2003210477A1 (en) * | 2002-01-09 | 2003-07-30 | Enzrel, Inc. | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
US20040242658A1 (en) * | 2003-01-08 | 2004-12-02 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
AU2004278030C1 (en) * | 2003-10-03 | 2010-12-02 | Portola Pharmaceuticals, Inc. | 2,4-Dioxo-3-quinazolinylaryl sulfonylureas |
ZA200804241B (en) * | 2005-11-03 | 2009-09-30 | Portola Pharm Inc | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quina-zolin-3-yl)-phenyl]-5-chlorothiophen-2-yl-sulfonylureas and forms and methods related thereto |
KR20100029746A (ko) * | 2007-05-02 | 2010-03-17 | 포톨라 파마슈티컬스, 인코포레이티드 | 직접 작용하는 가역적인 p2y12 억제제의 정맥내 및 경구 투여 |
US20090156620A1 (en) * | 2007-05-02 | 2009-06-18 | Portola Pharmaceuticals, Inc. | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
-
2008
- 2008-05-02 BR BRPI0810800-5A2A patent/BRPI0810800A2/pt not_active IP Right Cessation
- 2008-05-02 EP EP08747609A patent/EP2076510A2/en not_active Withdrawn
- 2008-05-02 CA CA002686221A patent/CA2686221A1/en not_active Abandoned
- 2008-05-02 KR KR1020097025052A patent/KR20100020455A/ko not_active Application Discontinuation
- 2008-05-02 AU AU2008247457A patent/AU2008247457A1/en not_active Abandoned
- 2008-05-02 MX MX2009011836A patent/MX2009011836A/es not_active Application Discontinuation
- 2008-05-02 US US12/114,742 patent/US20090042916A1/en not_active Abandoned
- 2008-05-02 WO PCT/US2008/062584 patent/WO2008137809A2/en active Application Filing
- 2008-05-02 JP JP2010506707A patent/JP2010526105A/ja not_active Withdrawn
- 2008-05-02 CN CN200880022604A patent/CN101720324A/zh active Pending
- 2008-05-02 EA EA200901474A patent/EA200901474A1/ru unknown
-
2009
- 2009-10-26 ZA ZA200907493A patent/ZA200907493B/xx unknown
- 2009-10-29 IL IL201829A patent/IL201829A0/en unknown
- 2009-10-30 GT GT200900282A patent/GT200900282A/es unknown
- 2009-10-30 TN TNP2009000452A patent/TN2009000452A1/fr unknown
- 2009-11-20 CO CO09132279A patent/CO6241155A2/es not_active Application Discontinuation
- 2009-11-26 MA MA32376A patent/MA31397B1/fr unknown
- 2009-12-02 EC EC2009009779A patent/ECSP099779A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0810800A2 (pt) | 2014-10-29 |
AU2008247457A1 (en) | 2008-11-13 |
CO6241155A2 (es) | 2011-01-20 |
EP2076510A2 (en) | 2009-07-08 |
ZA200907493B (en) | 2010-07-28 |
MX2009011836A (es) | 2010-05-20 |
IL201829A0 (en) | 2010-06-16 |
MA31397B1 (fr) | 2010-05-03 |
CN101720324A (zh) | 2010-06-02 |
ECSP099779A (es) | 2010-01-29 |
KR20100020455A (ko) | 2010-02-22 |
US20090042916A1 (en) | 2009-02-12 |
JP2010526105A (ja) | 2010-07-29 |
WO2008137809A2 (en) | 2008-11-13 |
WO2008137809A3 (en) | 2009-01-22 |
TN2009000452A1 (en) | 2011-03-31 |
EA200901474A1 (ru) | 2010-04-30 |
CA2686221A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200900282A (es) | [4(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2h-quinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo sales de sulfonilurea, y las formas y métodos relacionados con el mismo. | |
UY29549A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
CR11130A (es) | Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados | |
CR10662A (es) | Compuestos de metilpiridopirimidinona | |
DOP2011000174A (es) | Compuestos organicos | |
UY31260A1 (es) | Compuestos de pirazol, composiciones conteniendolos y aplicaciones. | |
CR9260A (es) | COMPUESTOS DE BIS ARILO Y HETEROARILO SUSTITUIDOS COMO ANTAGONISTAS SELECTIVOS DE 5HT2a | |
SV2008002542A (es) | Formas solidas cristalinas de tigeciclina y metodos para preparar los mismos ref. 01142.0379-00267 (am101946sv) | |
UY33469A (es) | Composiciones y metodos para modular la via de señalizacion de wnt | |
ECSP056063A (es) | 6-alquil o alquenil-4-aminopicolinatos y uso de los mismos como herbicidas | |
NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
CO6741214A2 (es) | Composiciones pesticidas y procesos relacionados | |
CR11548A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
EA201070966A1 (ru) | Фолаты, композиции и применение указанных композиций | |
CR20150254A (es) | Compuestos quimicos | |
ECSP10010058A (es) | Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas | |
CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
CR20120032A (es) | Derivados de 5-fluoro-2-oxopirimidinona-1(2h)-carboxamida substituida-n1 | |
CR11273A (es) | Derivados-2-ona disustituidos en 3, su preparacion y su aplicacion en terapeutica | |
UY33794A (es) | Inhibidores diméricos de las iap | |
UY33236A (es) | Inhibidores dimericos de las iap | |
SV2009003253A (es) | Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
CR9966A (es) | Acido 1-(1-(2-etoxietil-3-etil-7-(4-metilpiridin-2-ilamino)-1h-pirazolo[4,3-d]pirimidin-5-il)piperidina-4-carboxilico y las sales del mismo. | |
GT200600048A (es) | Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización. |